RESUMEN
This review describes two novel synthetic routes from (S)-pyroglutaminol to (+)-lactacystin, a potent inhibitor of the 20S proteasome and from d-gluconolactone derivative to zaragozic acid C, a potent squalene synthase inhibitor. In lactacystin synthesis, the photoinduced intermolecular C(sp3)-H alkynylation and intramolecular C(sp3)-H acylation chemoselectively and stereoselectively constructed the tetrasubstituted and trisubstituted carbon centers, respectively. In the synthesis of zaragozic acid C, the stereoselective installation of the two contiguous tetrasubstituted carbons was achieved by the photochemical intramolecular C(sp3)-H acylation of a densely oxygenated intermediate.
Asunto(s)
Acetilcisteína/análogos & derivados , Productos Biológicos/síntesis química , Compuestos Bicíclicos Heterocíclicos con Puentes/síntesis química , Inhibidores Enzimáticos/síntesis química , Oxígeno/química , Procesos Fotoquímicos , Inhibidores de Proteasoma/síntesis química , Acetilcisteína/síntesis química , Acilación , Alquilación , Carbono/química , Farnesil Difosfato Farnesil Transferasa/antagonistas & inhibidores , Radicales Libres/química , Gluconatos/química , Lactonas/química , Oxidación-Reducción , Complejo de la Endopetidasa Proteasomal , Pirroles/química , EstereoisomerismoRESUMEN
Fluorescent materials play an important role in biomedical fields. However, the main types of fluorescent materials suffer from several disadvantages especially the biotoxicity, which largely restrict its wider applications in biological fields. In this study, a highly efficient rare-earth-modified fluorescent material was successfully designed and fabricated based on polyhydroxyalkanoates, which are known as biodegradable and biocompatible materials. A new Functional-PHA polymer was microbially synthesized by engineered Halomonas bluephagenesis and was used as a basal matrix to generate the rare-earth-modified PHA. N-Acetyl-l-cysteine-grafted PHA (NAL-grafted-PHA) was first produced via a UV-initiated thiol-ene click reaction and the rare earth metal ions (Eu3+ and Tb3+) were subsequently chelated onto the NAL-grafted-PHA through the coordination effect. The composite material exhibited intense photoluminescence properties under UV laser excitation, indicating the excellent features as fluorescent material. The enhanced hydrophilicity and superior biocompatibility of rare-earth-chelated PHA were confirmed, suggesting its great potential application value in biomedical fields.
Asunto(s)
Materiales Biocompatibles/química , Colorantes Fluorescentes/química , Metales de Tierras Raras/química , Polihidroxialcanoatos/química , Acetilcisteína/síntesis química , Acetilcisteína/química , Materiales Biocompatibles/síntesis química , Química Clic , Colorantes Fluorescentes/síntesis química , Halomonas/química , Halomonas/metabolismo , Polihidroxialcanoatos/síntesis química , Polímeros/síntesis química , Polímeros/química , Compuestos de Sulfhidrilo/químicaRESUMEN
Primary S-nitrosothiols (RSNOs) have received significant attention for their ability to modulate NO signaling in many physiological and pathophysiological processes. Such actions and their potential pharmaceutical uses demand a better knowledge of their stability in aqueous solutions. Herein, we investigated the effects of concentration, temperature, pH, room light and metal ions on the long-term kinetic behavior of two representative primary RSNOs, S-nitrosoglutathione (GSNO) and S-nitroso-N-acetylcysteine (SNAC). The thermal decomposition of GSNO and SNAC were shown to be affected by the auto-catalytic action of the thiyl radicals. At 25⯰C in the dark and protected from the catalytic action of metal ions, GSNO and SNAC solutions 1â¯mM showed half-lives of 49 and 76 days, and apparent activation energies of 84⯱â¯14 and 90⯱â¯6â¯kJâ¯mol-1, respectively. Both GSNO and SNAC exhibited increased stability in the pH range 5-7. At high pH the decomposition pathway of GSNO involves the formation of an intermediate (GS-NO22-), which decomposes generating GSH and nitrite. GSNO solutions displayed lower sensitivity to the catalytic action of metal ions than SNAC and the exposure to room light led to a 5-fold increase in the initial rates of decomposition of both RSNOs. In all comparisons, SNAC solutions showed higher stability than GSNO solutions. These findings provide strategic information about the stability of GSNO and SNAC and may open new perspectives for their use as experimental or therapeutic NO donors.
Asunto(s)
Acetilcisteína/análogos & derivados , S-Nitrosoglutatión/química , Acetilcisteína/síntesis química , Acetilcisteína/química , Concentración de Iones de Hidrógeno , Cinética , Luz , S-Nitrosoglutatión/síntesis química , TemperaturaRESUMEN
N-Acetylcysteine (NAC) is a drug well known for its antimucolytic action, antioxidant activity and ability to protect cells from oxidative stress. Conjugation of NAC with double bonds in the main polymer chain of poly(globalide-co-ε-caprolactone) (PGlCL) through thiol-ene reaction is reported. Different globalide (Gl) (an unsaturated macrolactone) to ε-caprolactone (CL) ratios were employed for PGlCL synthesis. The polymeric materials (PGlCL-NAC) were evaluated in terms of the number of functionalized double bonds, thermal properties, affinity for water and antioxidant potential. PGlCL-NAC containing more globalide repeating units presented higher degree of functionalization, due to the higher number of double bonds available to react through thiol-ene coupling. For high globalide contents (Gl/CL ratios above 50/50), NAC coupling in PGlCL chains resulted in completely amorphous copolymers with a more hydrophilic character, which should enhance bioresorption and cell adhesion characteristics. Functionalization also gave rise to a thioether linkage, conferring to PGlCL-NAC an antioxidant character, important for biomedical applications, where the material could combat cellular oxidative-stress.
Asunto(s)
Acetilcisteína/química , Poliésteres/química , Compuestos de Sulfhidrilo/química , Acetilcisteína/síntesis química , Antioxidantes/farmacología , Benzotiazoles/química , Compuestos de Bifenilo/química , Picratos/química , Poliésteres/síntesis química , Espectroscopía de Protones por Resonancia Magnética , Ácidos Sulfónicos/química , Propiedades de SuperficieRESUMEN
N-acetylcysteine modified hyaluronic acid-paclitaxel (NAC-HA-PTX) conjugate was designed to improve the water solubility and oral bioavailability of PTX through mucosal bioadhesion ability. The average size of spherical NAC-HA-PTX micelles was 187 nm with a zeta potential of -25.38 mV. Mucin adhesion study showed that the amount of mucin adhered to NAC-HA-PTX micelles was 1.98-fold greater than that of hyaluronic acid-paclitaxel (HA-PTX) micelles. The fluorescence micrographs showed that the biodistribution sequence of coumarin 6-loaded micelles in the gastrointestinal tract was duodenum > jejunum > ileum, and NAC-modified micelles significantly exhibited better mucoadhesive properties than the corresponding unmodified ones. The pharmacokinetic study showed that the area under the curve (AUC0-24h) of NAC-HA-PTX micelles was 2.32-fold and 2.56-fold higher compared to that of HA-PTX micelles and PTX solution (Taxol) after oral administration, respectively. NAC-HA-PTX micelles appear to be a promising drug delivery system to improve the bioavailability of insoluble drugs for efficient tumor therapy via oral administration.
Asunto(s)
Acetilcisteína/uso terapéutico , Ácido Hialurónico/química , Membrana Mucosa/efectos de los fármacos , Paclitaxel/uso terapéutico , Acetilcisteína/administración & dosificación , Acetilcisteína/síntesis química , Acetilcisteína/farmacología , Adhesividad , Administración Oral , Animales , Liberación de Fármacos , Tracto Gastrointestinal/efectos de los fármacos , Humanos , Ácido Hialurónico/síntesis química , Células MCF-7 , Masculino , Micelas , Mucinas/química , Oxidación-Reducción , Paclitaxel/farmacocinética , Paclitaxel/farmacología , Tamaño de la Partícula , Ratas Sprague-Dawley , Electricidad Estática , Compuestos de Sulfhidrilo/química , Distribución Tisular/efectos de los fármacosRESUMEN
Reactive oxygen species (ROS), encompassing all oxygen radical or non-radical oxidizing agents, play key roles in disease progression. Controlled delivery of antioxidants is therapeutically relevant in such oxidant-stressed environments. Encapsulating small hydrophilic molecules into hydrophobic polymer microparticles via traditional emulsion methods has long been a challenge due to rapid mass transport of small molecules out of particle pores. We have developed a simple alteration to the existing water-in-oil-in-water (W/O/W) drug encapsulation method that dramatically improves loading efficiency: doping external water phases with drug to mitigate drug diffusion out of the particle during fabrication. PLGA microparticles with diameters ranging from 0.6 to 0.9 micrometers were fabricated, encapsulating high loads of 0.6-0.9 µm diameter PLGA microparticles were fabricated, encapsulating high loads of the antioxidant N-acetylcysteine (NAC), and released active, ROS-scavenging NAC for up to 5 weeks. Encapsulation efficiencies, normalized to the theoretical load of traditional encapsulation without doping, ranged from 96% to 400%, indicating that NAC-loaded external water phases not only prevented drug loss due to diffusion, but also doped the particles with additional drug. Antioxidant-doped particles positively affected the metabolism of oligodendrocyte progenitor cells (OPCs) under H2 O2 -mediated oxidative stress when administered both before (protection) or after (rescue) injury. Antioxidant doped particles improved outcomes of OPCs experiencing multiple doses of H2 O2 by increasing the intracellular glutathione content and preserving cellular viability relative to the injury control. Furthermore, antioxidant-doped particles preserve cell number, number of process extensions, cytoskeletal morphology, and nuclear size of H2 O2 -stressed OPCs relative to the injury control. These NAC-doped particles have the potential to provide temporally-controlled antioxidant therapy in neurodegenerative disorders such as multiple sclerosis (MS) that are characterized by continuous oxidative stress.
Asunto(s)
Acetilcisteína/farmacología , Antioxidantes/farmacología , Materiales Biocompatibles/síntesis química , Portadores de Fármacos/síntesis química , Ácido Láctico/síntesis química , Células Precursoras de Oligodendrocitos/efectos de los fármacos , Estrés Oxidativo , Ácido Poliglicólico/síntesis química , Acetilcisteína/síntesis química , Animales , Antioxidantes/síntesis química , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ratones , Células Precursoras de Oligodendrocitos/fisiología , Copolímero de Ácido Poliláctico-Ácido PoliglicólicoRESUMEN
Polycyclic aromatic hydrocarbons (PAH) are environmental carcinogens implicated as causes of cancer in certain industrial settings and in cigarette smokers. PAH require metabolic activation to exert their carcinogenic effects. One widely accepted pathway of metabolic activation proceeds through formation of "bay region" diol epoxides which are highly reactive with DNA and can cause mutations. Phenanthrene (Phe) is the simplest PAH with a bay region and an excellent model for the study of PAH metabolism. In previous studies in which [D10]Phe was administered to smokers, we observed higher levels of [D10]Phe-tetraols derived from [D10]Phe-diol epoxides in subjects who were null for the glutathione-S-transferase M1 (GSTM1) gene. We hypothesized that Phe-epoxides, the primary metabolites of Phe, were detoxified by glutathione conjugate formation, which would result ultimately in the excretion of the corresponding mercapturic acids in urine. We synthesized the four stereoisomeric mercapturic acids that would result from attack of glutathione on Phe-epoxides followed by normal processing of the conjugates. We also synthesized the corresponding dehydrated metabolites and sulfoxides. These 12 standards were used in liquid chromatography-nanoelectrospray ionization-high resolution tandem mass spectrometry analysis of urine samples from smokers and creosote workers, the latter exposed to unusually high levels of PAH. Only the sulfoxide derivatives were consistently detected in the urine of creosote workers; none of the compounds was detected in the urine of smokers. These results demonstrate a new pathway of PAH-mercapturic acid formation, but do not provide an explanation for the role of GSTM1 null status on Phe-tetraol formation.
Asunto(s)
Acetilcisteína/orina , Fenantrenos/metabolismo , Hidrocarburos Policíclicos Aromáticos/metabolismo , Acetilcisteína/síntesis química , Cromatografía Líquida de Alta Presión , Glutatión Transferasa/genética , Glutatión Transferasa/metabolismo , Humanos , Fenantrenos/química , Hidrocarburos Policíclicos Aromáticos/química , Estereoisomerismo , Espectrometría de Masas en TándemRESUMEN
In this study, a novel type of pH-responsive polymer PyHES-NAC (2-hydroxy-3-(2-propynyloxy) propyl hydroxyethyl starch (PyHES)) - (N-acetyl-cysteine (NAC)) was synthesized. First, PyHES was prepared via hydrophobic modification of hydroxyl groups in hydroxyethyl starch (HES) with propynylglycidyl ether (PGE), and then pH-responsive carboxylic acid group was connected to propynyl group via thiol-yne click reaction with NAC. Aqueous PyHES-NAC solutions exhibited a good transference between hydrophobic (or self-assembly) and hydrophilic static along with the change of pH value and protective properties of drugs under acidic conditions. 10.0% DOX was released under artificial gastric fluid after 2 h, whereas an immediate release (above 80%) was observed under artificial intestinal fluid. Drug loading capacity of PyHES-NAC was increased by the increase of degree of substitution (DS) of hydrophobic propynyl groups in PyHES, and 41 wt% DOX Loading capacity was the highest value in our study area.
Asunto(s)
Acetilcisteína/química , Acetilcisteína/síntesis química , Portadores de Fármacos/química , Portadores de Fármacos/síntesis química , Almidón/química , Administración Oral , Técnicas de Química Sintética , Doxorrubicina/administración & dosificación , Doxorrubicina/química , Liberación de Fármacos , Concentración de Iones de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Conformación MolecularRESUMEN
Numerous reports suggest that aberrant activations of STAT3 and NF-κB promote survival and proliferation of multiple myeloma (MM) cells. In the present report, we demonstrate that a synthetic S-nitrosothiol compound, S-nitroso-N-acetylcysteine (SNAC), inhibits proliferation and survival of multiple MM cells via S-nitrosylation-dependent inhibition of STAT3 and NF-κB. In human MM cells (e.g. U266, H929, and IM-9 cells), SNAC treatment increased S-nitrosylation of STAT3 and NF-κB and inhibited their activities. Consequently, SNAC treatment resulted in MM cell cycle arrest at G1/S check point and inhibited their proliferation. SNAC also decreased the expression of cell survival factors and increased the activities of caspases, thus increased sensitivity of MM cells to melphalan, a chemotherapeutic agent for MM. In U266 xenografted mice, SNAC treatment decreased the activity of STAT3 and reduced the growth of human CD138 positive cells (U266 cells) in the bone marrow and also reduced their production of human IgE into the serum. Taken together, these data document the S-nitrosylation mediated inhibition of MM cell proliferation and cell survival via inhibition of STAT3 and NF-κB pathways and its efficacy in animal model of MM.
Asunto(s)
Acetilcisteína/análogos & derivados , Mieloma Múltiple/metabolismo , FN-kappa B/genética , Factor de Transcripción STAT3/genética , Acetilcisteína/administración & dosificación , Acetilcisteína/síntesis química , Animales , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Resistencia a Antineoplásicos/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Ratones , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/patología , Transducción de Señal/efectos de los fármacos , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Cyslabdan was isolated from the culture broth of Streptomyces sp. K04-0144 as a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus. We accomplished the synthesis of cyslabdan according to a previously reported structure. However, we subsequently found that this structure was incorrect; our analysis of natural cyslabdan showed that it possessed R stereochemistry at the C8 position, not S, as had previously been reported. Thus, we completed the protecting-group-free synthesis of the correct structure of cyslabdan, which is described herein.
Asunto(s)
Acetilcisteína/análogos & derivados , Diterpenos/química , Diterpenos/síntesis química , Acetilcisteína/síntesis química , Acetilcisteína/química , Conformación Molecular , Streptomyces/químicaRESUMEN
The transcription factor STAT3 is a potential target for the treatment of castration-resistant prostate cancer. Galiellalactone (1), a direct inhibitor of STAT3, prevents the transcription of STAT3 regulated genes. In this study we characterized 6 (GPA512, Johansson , M. ; Sterner , O. Patent WO 2015/132396 A1, 2015 ), a prodrug of 1. In vitro studies showed that 6 is rapidly converted to 1 in plasma and is stable in a buffer solution. The pharmacokinetics of 6 following a single oral dose indicated that the prodrug was rapidly absorbed and converted to 1 with a tmax of 15 min. Oral administration of 6 in mice increased the plasma exposure of the active parent compound 20-fold compared to when 1 was dosed orally. 6 treated mice bearing DU145 xenograft tumors had significantly reduced tumor growth compared to untreated mice. The favorable druglike properties and safety profile of 6 warrant further studies of 6 for the treatment of castration-resistant prostate cancer.
Asunto(s)
Acetilcisteína/análogos & derivados , Antineoplásicos/farmacología , Neoplasias Experimentales/patología , Profármacos/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/patología , Factor de Transcripción STAT3/antagonistas & inhibidores , Acetilcisteína/síntesis química , Acetilcisteína/química , Acetilcisteína/farmacología , Animales , Antineoplásicos/síntesis química , Antineoplásicos/química , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Masculino , Ratones , Ratones Desnudos , Modelos Moleculares , Estructura Molecular , Neoplasias Experimentales/tratamiento farmacológico , Profármacos/síntesis química , Profármacos/química , Factor de Transcripción STAT3/metabolismo , Relación Estructura-Actividad , Células Tumorales CultivadasRESUMEN
Herein, we report a new synthetic route from (S)-pyroglutaminol to (+)-lactacystin, a potent inhibitor of the 20S proteasome. The photoinduced intermolecular C(sp(3))-H alkynylation and intramolecular C(sp(3))-H acylation chemo- and stereoselectively constructed the tetra- and trisubstituted carbon centers, respectively. The obtained bicycle was transformed into the target compound in a concise manner. The present total synthesis demonstrates the power of the direct C(sp(3))-H functionalizations for the assembly of multiple functionalized structures of natural products.
Asunto(s)
Acetilcisteína/análogos & derivados , Productos Biológicos/síntesis química , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Inhibidores de Proteasoma/síntesis química , Pirroles/química , Acetilcisteína/síntesis química , Acetilcisteína/química , Acetilcisteína/farmacología , Acilación , Productos Biológicos/química , Productos Biológicos/farmacología , Estructura Molecular , Inhibidores de Proteasoma/química , Inhibidores de Proteasoma/farmacología , EstereoisomerismoRESUMEN
Omuralide, a transformation product of the microbial metabolite lactacystin, was the first molecule discovered as a specific inhibitor of the proteasome and is unique in that it specifically inhibits the proteolytic activity of the 20S subunit of the proteasome without inhibiting any other protease activities of the cell. The total syntheses of omuralide and (+)-lactacystin are reported. An important key intermediate is synthesized at an early stage, which allows analogues of these two natural products to be made readily.
Asunto(s)
Acetilcisteína/análogos & derivados , Química Farmacéutica/métodos , Inhibidores de Cisteína Proteinasa/síntesis química , Lactonas/síntesis química , Acetilcisteína/análisis , Acetilcisteína/síntesis química , Acetilcisteína/farmacología , Apoptosis/efectos de los fármacos , Cristalografía por Rayos X , Inhibidores de Cisteína Proteinasa/análisis , Inhibidores de Cisteína Proteinasa/farmacología , Humanos , Lactonas/análisis , Lactonas/farmacología , Espectroscopía de Resonancia Magnética , Neoplasias/tratamiento farmacológico , Complejo de la Endopetidasa Proteasomal/metabolismo , Inhibidores de Proteasoma , EstereoisomerismoRESUMEN
Nitric oxide (NO) has been shown to act as a potent antifibrogenic agent by decreasing myofibroblast differentiation. S-Nitroso-N-acetylcysteine (SNAC), a NO donor, attenuates liver fibrosis in rats, but the cellular and molecular mechanisms on liver myofibroblast-like phenotype still remain unknown. Here, we investigate the antifibrotic effects of SNAC on hepatic stellate cells, the major fibrogenic cell type in the liver. A murine GRX cell line was incubated with SNAC (100µM) or vehicle (control group) for 72h. Cell viability was measured by MTT colorimetric assay and the conversion of myofibroblast into quiescent fat-storing cell phenotype was evaluated by Oil-Red-O staining. TGFß-1, TIMP-1, and MMP-13 levels were measure in the supernatant by ELISA. Profibrogenic- and fibrolytic-related gene expression was quantified using real-time qPCR. SNAC induced phenotype conversion of myofibroblast-like phenotype into quiescent cells. SNAC decreased gene and protein expression of TGFß-1 and MMP-2 compared to control groups. Besides, SNAC down-regulated profibrogenic molecules and up-regulated MMP-13 gene expression, which plays a key role in the degradation of interstitial collagen in liver fibrosis. In conclusion, these findings demonstrate that SNAC efficiently can modulate the activation and functionality of murine hepatic stellate cells and could be considered as an antifibrotic treatment to human liver fibrosis.
Asunto(s)
Acetilcisteína/análogos & derivados , Desdiferenciación Celular/efectos de los fármacos , Células Estrelladas Hepáticas/citología , Células Estrelladas Hepáticas/efectos de los fármacos , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/patología , Acetilcisteína/síntesis química , Acetilcisteína/química , Acetilcisteína/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Células Estrelladas Hepáticas/metabolismo , Cirrosis Hepática/metabolismo , RatonesRESUMEN
The purpose of the present study was to determine if trihydroxymethamphetamine (THMA), a metabolite of methylenedioxymethamphetamine (MDMA, "ecstasy"), or its thioether conjugate, 6-(N-acetylcystein-S-yl)-2,4,5-trihydroxymethamphetamine (6-NAC-THMA), play a role in the lasting effects of MDMA on brain serotonin (5-HT) neurons. To this end, novel high-yield syntheses of THMA and 6-NAC-THMA were developed. Lasting effects of both compounds on brain serotonin (5-HT) neuronal markers were then examined. A single intraventricular injection of THMA produced a significant lasting depletion of regional rat brain 5-HT and 5-hydroxyindoleacetic acid (5-HIAA), consistent with previous reports that THMA harbors 5-HT neurotoxic potential. The lasting effect of THMA on brain 5-HT markers was blocked by the 5-HT uptake inhibitor fluoxetine, indicating that persistent effects of THMA on 5-HT markers, like those of MDMA, are dependent on intact 5-HT transporter function. Efforts to identify THMA in the brains of animals treated with a high, neurotoxic dose (80 mg/kg) of MDMA were unsuccessful. Inability to identify THMA in the brains of these animals was not related to the unstable nature of the THMA molecule because exogenous THMA administered intracerebroventricularly could be readily detected in the rat brain for several hours. The thioether conjugate of THMA, 6-NAC-THMA, led to no detectable lasting alterations of cortical 5-HT or 5-HIAA levels, indicating that it lacks significant 5-HT neurotoxic activity. The present results cast doubt on the role of either THMA or 6-NAC-THMA in the lasting serotonergic effects of MDMA. The possibility remains that different conjugated forms of THMA or oxidized cyclic forms (e.g., the indole of THMA) play a role in MDMA-induced 5-HT neurotoxicity in vivo.
Asunto(s)
Acetilcisteína/análogos & derivados , Inhibidores de Captación Adrenérgica/síntesis química , Inhibidores de Captación Adrenérgica/toxicidad , Metanfetamina/análogos & derivados , N-Metil-3,4-metilenodioxianfetamina/análogos & derivados , Acetilcisteína/síntesis química , Acetilcisteína/química , Acetilcisteína/toxicidad , Inhibidores de Captación Adrenérgica/química , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Ácido Hidroxiindolacético/metabolismo , Masculino , Metanfetamina/síntesis química , Metanfetamina/química , Metanfetamina/toxicidad , N-Metil-3,4-metilenodioxianfetamina/síntesis química , N-Metil-3,4-metilenodioxianfetamina/química , N-Metil-3,4-metilenodioxianfetamina/toxicidad , Síndromes de Neurotoxicidad/metabolismo , Neurotoxinas/síntesis química , Neurotoxinas/química , Neurotoxinas/toxicidad , Ratas , Ratas Sprague-Dawley , Serotonina/metabolismoRESUMEN
Oxidative stress and/or low cellular glutathione (GSH) levels are associated with the development and progression of numerous pathological conditions. Cells possess various antioxidant protection mechanisms, including GSH and phase II detoxifying enzymes. N-acetylcysteine (NAC) supplies cells with cysteine to increase GSH level but its efficacy is relatively low because of its limited tissue penetration. Allicin (diallyl thiosulfinate), a reactive sulfaorganic compound, increases cellular GSH and phase II detoxifying enzymes in vascular endothelial cells (EC). A novel compound was designed: S-allylmercapto-N-acetylcysteine (ASSNAC), a conjugate of S-allyl mercaptan (a component of allicin) and NAC. Both ASSNAC and NAC increased cellular GSH of ECs, reaching a maximum of up to four- and threefold increase after exposure for 24 or 6 h at a concentration of 0.2 or 1 mM, respectively. ASSNAC induced nuclear translocation of the activated transcription factor Nrf2 and expression of phase II detoxifying enzymes. EC exposure to tBuOOH resulted in 75% cytotoxicity, and pretreatment of cultures with 0.2 mM ASSNAC or 2mM NAC reduced cytotoxicity to 20 and 42%, respectively. In conclusion, ASSNAC is superior to NAC in protecting cells from oxidative stress because of its ability to up-regulate both GSH and the expression of phase II detoxifying enzymes.
Asunto(s)
Acetilcisteína/farmacología , Antioxidantes/farmacología , Citoprotección , Células Endoteliales/metabolismo , Glutatión/metabolismo , Acetilcisteína/análogos & derivados , Acetilcisteína/síntesis química , Animales , Antioxidantes/síntesis química , Aorta/citología , Aorta/metabolismo , Bovinos , Células Cultivadas , Cisteína/metabolismo , Disulfuros , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Fase II de la Desintoxicación Metabólica , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ácidos Sulfínicos/química , Activación Transcripcional , Regulación hacia Arriba , terc-Butilhidroperóxido/toxicidadRESUMEN
A simple and sensitive indirect noncompetitive enzyme immunoassay to quantitate mercapturic acid-aflatoxin B1 (AFB1) adduct in rat urine is reported. A novel procedure was developed for in vitro synthesis of an immunogen, bovine serum albumen-glutathione-aflatoxin B1 (BSA-GSH-AFB1) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. Sulphydryl group's analysis confirmed the conjugation of-SH groups to AFB1. Thin-layer chromatography and spectral analysis (absorption, fluorescence, and Fourier transform infrared) of the conjugates further confirmed the formation of the adducts. Polyclonal antibodies specific to mercapturic acid-AFB1 adduct were produced against BSA-GSH-AFB1. The assay was found to be linear in the range of 100 pg-100 ng of the analyte (y = a + bx). A 50% displacement of BSA-GSH-AFB1 antibodies was achieved at an inhibitory concentration (IC50) of 11.9 ng GSH-AFB1 (r2 = 0.98) and 1.22 ng N-acetyl-L-cysteine (NAC)-AFB1 (r2 = 0.98). Spiking 5 microg/mL of reference standard to the control rat urine showed a recovery of 98 +/- 2%. The immunoassay was validated in a rodent model exposed to a single oral dose of 1 mg/kg body mass of pure AFB1. The excretion of NAC-AFB1 adduct was quantitated at the end of 24 h. The concentration of the NAC-AFB1 adduct excreted in urine as determined by the immunoassay was found to be in the range of 3.22-5.97 microg/mg creatinine. The present method may find wide application as a biochemical tool in molecular epidemiological and intervention studies with respect to human exposure to dietary aflatoxins.
Asunto(s)
Acetilcisteína/orina , Aflatoxina B1/orina , Técnicas para Inmunoenzimas/métodos , Acetilcisteína/síntesis química , Aflatoxina B1/síntesis química , Aflatoxina B1/inmunología , Aflatoxina B1/toxicidad , Animales , Formación de Anticuerpos , Bovinos , Cromatografía en Capa Delgada , Contaminación de Alimentos/análisis , Glutatión/química , Humanos , Técnicas para Inmunoenzimas/normas , Técnicas para Inmunoenzimas/estadística & datos numéricos , Masculino , Ovalbúmina/química , Conejos , Ratas , Ratas Endogámicas F344 , Estándares de Referencia , Sensibilidad y Especificidad , Albúmina Sérica Bovina/química , Espectroscopía Infrarroja por Transformada de FourierRESUMEN
N-Acetylcysteine (NAC) conjugates of the five major bile acids occurring in man were synthesized in order to investigate the possible formation in vivo of these conjugates. Upon collision-induced dissociation, structurally informative daughter ions were observed. The transformation of cholyl-adenylate and cholyl-CoA thioester into a N-acetyl-S-(cholyl)cysteine by rat hepatic glutathione S-transferase was confirmed by liquid chromatography/electrospray ionization-linear ion trap mass spectrometry (LC/ESI-MS(2)). Lithocholic acid was administered orally to bile duct-ligated rats that also received NAC intraperitoneally. The NAC conjugate of lithocholic acid was identified in urine by means of LC/ESI-MS(2). Rapid hydrolysis of the BA-NAC conjugates by rabbit liver carboxylesterase was found, demonstrating the possible labile nature of the NAC conjugates formed in the liver.
Asunto(s)
Acetilcisteína/metabolismo , Ácidos y Sales Biliares/metabolismo , Colestasis/metabolismo , Cromatografía Liquida/métodos , Espectrometría de Masa por Ionización de Electrospray/métodos , Acetilcisteína/síntesis química , Acetilcisteína/química , Animales , Ácidos y Sales Biliares/síntesis química , Ácidos y Sales Biliares/química , Carboxilesterasa/metabolismo , Modelos Animales de Enfermedad , Humanos , Hígado/química , Hígado/metabolismo , Masculino , Conejos , RatasRESUMEN
The development of a highly efficient and stereoselective methodology for the preparation of beta-hydroxy-alpha-amino acids is described. Nucleophilic addition of enolates of tricyclic iminolactones 1a and 1b to aldehydes in the presence of 6 equiv of lithium chloride in THF at -78 degrees C leads to aldol adducts in good yield (63-86%) and high diastereoselectivity (up to >25:1 dr). Subsequently, hydrolysis of the aldol adducts under acidic conditions leads to the corresponding beta-hydroxy-alpha-amino acids in good yields (up to 83%) and excellent enantiomeric excesses (99% ee) with good recovery yields of the chiral auxiliaries 6 and 7. This methodology was applied to the facile synthesis of the key intermediate for lactacystin along with several isomers.
Asunto(s)
Acetilcisteína/análogos & derivados , Aminoácidos/síntesis química , Acetilcisteína/síntesis química , Aldehídos/química , Aminoácidos/química , Hidrólisis , Estereoisomerismo , Especificidad por SustratoRESUMEN
The inhibition of protein degradation through the ubiquitin-proteasome pathway is a recently developed approach to cancer treatment which extends the range of cellular target for chemotherapy. This therapeutic strategy is very interesting since the proteasomes carry out the regulated degradation of unnecessary or damaged cellular proteins, a process that is dysregulated in many cancer cells. Based on this hypothesis, the proteasome complex inhibitor Bortezomib was approved for use in multiple myeloma patients by FDA in 2003. Drug discovery programs in academy and the pharmaceutical industry have developed a range of synthetic and natural inhibitors of the 20S proteasome core particle that have entered human clinical trials as significant anti-cancer leads. The main results from the use of proteasome inhibition in cancer chemotherapy, the structure of several proteasome inhibitors and their synthesis is going to be reviewed in this paper.